Biphosphonates-related osteonecrosis of the jaw: Clinical and physiopathological considerations

References

• MarxRPamidronate (Aredia) and zoledonate (Zometa) induced avascular necrosis of the jaws: a growing epidemicJ Oral Maxillofac Surg2003611115111712966493
   PubMed Web of Science ®Google Scholar
• RuggieroSLMehrotaBOsteonecrosis of the jaws associated with the use of bisphophonates; a review of 63 casesJ Oral Maxillofac Surg20046252753415122554
   PubMed Web of Science ®Google Scholar
• MarxRESawatariYFortinMBroumandVBisphosphonates-induced exposed bone (osteonecrosis/osteopetrosis) of the jaws: risk factors, recognition, prevention and treatmentJ Oral Maxillofac Surg2005631567157516243172
   PubMed Web of Science ®Google Scholar
• MiglioratiCACasigliaJEpsteinJJacobsenPLSiegelMAWooSBManaging the care of patients with bisphosphonate-associated osteonecrosis: an American Academy of Oral Medicine position paperJ Am Dent Assoc200513616581668 Erratum in: J Am Dent Assoc. 2006;137:26.16383047
   PubMed Web of Science ®Google Scholar
• BadrosAWeichelDOsteonecrosis of the jaw in multiple myeloma patients: clinical features and risk factorsJ Clin Oncol20062494595216484704
   PubMed Web of Science ®Google Scholar
• DimopoulosMAKastritisEOsteonecrosis of the jaw in patient with multiple myeloma treated with bisphosphonates: evidence of increased risk after treatment with zoledronic acidHaematologica20069196897116757414
   PubMed Web of Science ®Google Scholar
• TosiPZamagniEOsteonecrosis of the jaw in newly diagnosed multiple myeloma patient treated with zoledronic acid and thalidomide-dexamethasoneBlood20061083951395217114572
   PubMed Web of Science ®Google Scholar
• MajorPPCookRJMultiple event analysis of zoledronic acid trials in patients with cancer metastases to boneProc Am Soc Clin Oncol200322762
   Web of Science ®Google Scholar
• RosenLSGordonDHZoledronic acid is superior to pamidronate for the treatment of bone metastases in breast carcinoma patients with at least one ostelytic lesionCancer2004100364314692022
   PubMed Web of Science ®Google Scholar
• BerensonJRHillnerBEKyleRAAmerican Society of Clinical Oncology Bisphosphonates Expert Panel. American Society of Clinical Oncology clinical practice guidelines: the role of bisphosphonates in multiple myelomaJ Clin Oncol2002203719373612202673
   PubMed Web of Science ®Google Scholar
• BodyJJBreast cancer: bisphosphonates therapy for metastatic bone diseaseClin Cancer Res20061220 Suppl62586263
   Web of Science ®Google Scholar
• American Association of Oral and Maxillofacial SurgeonsPosition paper on bisphosphonate-related osteonecrosis of the jaws, approved by the Board of Trustees September 25, 2006 [cited on 2008 Dec 6]Available from http://www.aaoms.org/docs/position_papers/osteonecrosis.pdf
   Google Scholar
• DurieBGMKatzMOsteonecrosis of the jaws and bisphosphonatesN Engl J Med200535399102discussion 99–102.16000365
   PubMed Web of Science ®Google Scholar
• HillnerBEIngleJNASCO 2003 update on the role of Bisphosphonates and bone health issues in women with breast cancerJ Clin Oncol2003214042
   Web of Science ®Google Scholar
• BilezikianJPOsteonecrosis of the jaw. Do Bisphosphonates pose a risk?N Engl J Med20063552278228117135582
   PubMed Web of Science ®Google Scholar
• RuggieroSLFantasiaJCarlsonEBisphosphonate-related osteonecrosis of the jaw: background and guidelines for diagnosis, staging and managementOral Surg Oral Med Oral Path Oral Rad Endod2006102433441
   PubMed Web of Science ®Google Scholar
• ContePFGuarnieriVSafety of intravenous and oral bisphosphonates and compliance with dosing regimensOncologist20049Suppl 4283715459427
   PubMed Web of Science ®Google Scholar
• PetersonLJEllisEContemporary oral and maxillofacial surgeryNew YorkMosby1998418432
   Google Scholar
• VialePHLinAExposed bone in oral cavitiesJ Clin Oncol Nurs20059355357
   PubMedGoogle Scholar
• FicarraGBeninatiFRubinoIOsteonecrosis of the jaws in periodontal patients with a history of bisphosphonates treatmentJ Clin Periodontol20053211251128
   Web of Science ®Google Scholar
• ChiandussiSBiasiottoMDoreFCavalliFCovaMADi LeonardaRClinical and diagnostic imaging of bisphosphonate-associated osteonecrosis of the jawsDentomaxillofac Radiol20063523624316798918
   PubMed Web of Science ®Google Scholar
• HermansRFossionEIoannidesCVan de BogaertWGhekiereJBaertALCT findings in osteoradionecrosis of the mandibuleSkeletal Radiol19962531368717116
   PubMed Web of Science ®Google Scholar
• WooSBHellsteinJWKalmarJRNarrative [corrected] review: bisphosphonates and osteonecrosis of the jawsAnn Intern Med200614475376116702591
   PubMed Web of Science ®Google Scholar
• ReszaAARodanGANitrogen-containing bisphosphonates mechanism of actionMini Rev Med Chem2004471171915379639
   PubMed Web of Science ®Google Scholar
• GreenJRBisphosphonates preclinical reviewOncologist20049Suppl 431315459425
   PubMed Web of Science ®Google Scholar
• NaseJBSuzukiJBOsteonecrosis of the jaw and oral bisphosphonate treatmentJ Am Dent Assoc20061371115111916873327
   PubMed Web of Science ®Google Scholar
• VescoviPMerigoEMeletMManfrediMBisphosphonate-associated osteonecrosis (BON) of the jaws: a possibile treatment?J Oral Maxillofac Surg2006641460146216916694
   PubMed Web of Science ®Google Scholar
• TonelliPDuvinaMBrancatoLVivianiCOsteonecrosis of the jaw: A dramatic complication in patients with history of bisphosphonates treatment and bone disease. Study of 19 casesMonaco: Poster Session in International Symposium, OsteologyMay 10–12, 2007
   Google Scholar
• BorgioliATonelliPBrandiMLGiombettiADuvinaMSpinelliGBrancatoLOsteonecrosi dei mascellari da bifosfonati. L'Esperienza Fiorentina: Aspetti clinici e terapeuticiAlessandria: Abstract Presentation in Workshop: BRONJ, present and future, gennaio 20, 2007.
   Google Scholar
• DurieBGOsteonecrosis of the jaw and bisphosphonatesN Engl J Med20053539910216000365
   PubMed Web of Science ®Google Scholar
• MiglioratiCASchubertMMPetersonDESenedaLMBisphosphonate-associated osteonecrosis of mandibular boneCancer20051041839315929121
   PubMed Web of Science ®Google Scholar
• Jimenez-SorianoYBaganJVBisphosphonates as a new cause of drug-induced jaw osteonecrosis: an updateMed Oral Patol Oral Cir Bucal200510Suppl 2889115627912
   PubMedGoogle Scholar
• RobinsonNABisphosphonates a word of cautionAnn Acad Med Singapore.200433484915389307
   PubMed Web of Science ®Google Scholar
• Novartis Pharmaceuticals CorporationAppendix 11: Expert panel recommendation for the prevention, diagnosis and treatment of osteonecrosis of the jaw. Oncologic Drugs Advisory Committee (ODAC), Meeting March 4, 2005 [cited 2008 Dec 6]. Available from: http://www.fda.gov/OHRMS/DOCKETS/AC/05/briefing/2005-4095B2_02_12-Novartis-Zometa-App-11.pdf
   Google Scholar
• MehrotraBRuggieroSBisphosphonates complications including osteonecrosis of the jawHematology Am Soc Hematolol Educ Program20063356360
   Google Scholar
• RuggieroSLGralowJMarxREHoffAOSchubertMMHurynJMPractical guidelines for the prevention, diagnosis and treatment of osteonecrosis of the jaw in patients with cancerJ Clin Oncol Prac20062714
   PubMedGoogle Scholar
• ZavrasALZhuSBisphosphonates are associated with increased risk for jaw surgery in medical claims data: is it osteonecrosis?J Oral Maxillofac Surg20066491792316713806
   PubMed Web of Science ®Google Scholar
• MartinsMSaraceniGKogaDHFeberOOlivetra dos SantosMZardettoCTreatment of avascular osteonecrosis of the mandibule in cancer patients with a history of bisphosphonate therapy by combining bone resection and autologous platelet-rich plasma: report of 3 casesJ Oral Maxillofac Surg20076534935517236949
   PubMed Web of Science ®Google Scholar
• ShimuraKShimazakiCTaniguchiKHyperbaric oxygen in addition to antibiotic therapy is effective for bisphosphonate-induced osteonecrosis of the jaw in a patient with multiple myelomaInt J Hematol20068434334517118761
   PubMed Web of Science ®Google Scholar
• TonelliPBrancatoLPaggettiBDuvinaMBorgioliALa terapia iperbarica nel trattamento dell'osteomielite dei mascellariRomeSessione Poster Collegio dei Docenti in Odontoiatria Roma2004
   Google Scholar
• GiombettiABorgioliABrancatoLSpinelliGL'Osteomielite farmacologica dei mascellariMontecatini Terme: Poster Presentation, Congresso Nazionale della Società Italiana di Chirurgia Orale (SICO): la Pianificazione del trattamento in Chirurgia OraleOttobre 7–8, 2005
   Google Scholar
• BorgioliADuvinaMBrancatoLDuvinaGTonelliPBad and good bisphosphonates in implantology: Clinical reportRomeSessione Poster Collegio dei Docenti in Odontoiatria Roma2007
   Google Scholar
• MavrokokkiTChengASteinBGossANature and frequency of bisphosphonate-associated osteonecrosis of the jaws in AustraliaJ Oral Maxillofac Surg20076541542317307586
   PubMed Web of Science ®Google Scholar